Viewing Study NCT00410202


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT00410202
Status: COMPLETED
Last Update Posted: 2013-11-21
First Post: 2006-12-11
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
Sponsor: Bristol-Myers Squibb
Organization: